Botulinum TOX TYP a 1S
Ended Awarded
- Contract number
- SPE2DX25FKVGZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $37,006
Award facts
- Contract value 100% obligated
- $37,005.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $37,005.60 for Botulinum Toxin Type A 1S on April 25, 2025, with completion targeted for May 15, 2025. The award was issued without a set-aside designation by the Medical Supply Chain, a defense-focused federal agency. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for defense-related healthcare contracts. The company specializes in distributing branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to military and federal healthcare systems. With a SAM.gov registration dating to 2001, the firm maintains a robust portfolio of federal contract awards covering diverse pharmaceutical products ranging from specialty medications and oncology treatments to vaccines and medical devices, positioning it as a key vendor for supporting the medical supply requirements of the Department of Defense.
Quick answers
Who was awarded contract SPE2DX25FKVGZ?
SPE2DX25FKVGZ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on April 25, 2025.
How much is contract SPE2DX25FKVGZ worth?
The government has obligated $37,006 on SPE2DX25FKVGZ.
Is contract SPE2DX25FKVGZ an order under another contract?
Yes. SPE2DX25FKVGZ is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKVGZ competed?
The extent of competition for SPE2DX25FKVGZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award